Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells (Q40694264)

22 September 2017

title

Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells (English)

1 reference

22 September 2017

1 reference

1 reference

metastatic breast cancer

1 reference

4

1 reference

22 September 2017

Pedro J Real

1

1 reference

22 September 2017

Angels Sierra

2

1 reference

22 September 2017

Ana De Juan

3

1 reference

22 September 2017

Jose M Lopez-Vega

5

1 reference

22 September 2017

Jose L Fernandez-Luna

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

21

1 reference

22 September 2017

issue

50

1 reference

22 September 2017

page(s)

7611-7618

1 reference

Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Studies of epidermal growth factor receptor inhibition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

ErbB-2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Escaping cell death: survival proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Prognostic significance of apoptosis regulators in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Antiapoptotic protein Bcl-x(L) is up-regulated during megakaryocytic differentiation of CD34(+) progenitors but is absent from senescent megakaryocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Mechanism of STAT3 activation by insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

7 January 2021

Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

7 January 2021

Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

7 January 2021

Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

7 January 2021

Estrogen suppression of EGFR expression in breast cancer cells: a possible mechanism to modulate growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206004

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206004

1 reference

Dimensions Publication ID

22 September 2017

1029510021

0 references

1 reference